Advancing Therapeutics Through Personalized Medicine in Trials for Asbestos-Related Diseases
Personalized medicine is revolutionizing clinical trials for mesothelioma by tailoring treatments to individual patient profiles, potentially enhancing efficacy and outcomes. How can these advancements reshape the landscape of mesothelioma therapy? Incorporating biomarkers and genetic insights,…